CoChat

HSP72 protects against obesity-induced insulin resistance

Open access

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Abstract

Patients with type 2 diabetes have reduced gene expression of heat shock protein (HSP) 72, which correlates with reduced insulin sensitivity. Heat therapy, which activates HSP72, improves clinical parameters in these patients. Activation of several inflammatory signaling proteins such as c-jun amino terminal kinase (JNK), inhibitor of κB kinase, and tumor necrosis factor-α, can induce insulin resistance, but HSP 72 can block the induction of these molecules in vitro . Accordingly, we examined whether activation of HSP72 can protect against the development of insulin resistance. First, we show that obese, insulin resistant humans have reduced HSP72 protein expression and increased JNK phosphorylation in skeletal muscle. We next used heat shock therapy, transgenic overexpression, and pharmacologic means to overexpress HSP72 either specifically in skeletal muscle or globally in mice. Herein, we show that regardless of the means used to achieve an elevation in HSP72 protein, protection against diet- or obesity-induced hyperglycemia, hyperinsulinemia, glucose intolerance, and insulin resistance was observed. This protection was tightly associated with the prevention of JNK phosphorylation. These findings identify an essential role for HSP72 in blocking inflammation and preventing insulin resistance in the context of genetic obesity or high-fat feeding.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0705799105

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. 10.1016/s0021-9258(19)84059-0 · doi:10.1016/s0021-9258(19)84059-0
  2. A Kolonics, et al., BGP-15, a new type of insulin sensitizer. Diabetes 55, A-483, (abstr). (2006).

Cited by

See all 619

Metadata

Authors
Chung, J., Nguyen, A.-K., Henstridge, D. C., Holmes, A. G., Chan, M. H. S., Mesa, J. L., Lancaster, G. I., Southgate, R. J., Bruce, C. R., Duffy, S. J., Horvath, I., Mestril, R., Watt, M. J., Hooper, P. L., Kingwell, B. A., Vigh, L., Hevener, A., & Febbraio, M. A.
Affiliations
  • *Cellular and Molecular Metabolism Laboratory,
  • University of California San Diego (US)
  • Clinical Physiology, and
  • Baker Heart and Diabetes Institute (AU)
  • Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, 6726, Szeged, Hungary;
  • Loyola University Medical Center (US)
  • The University of Melbourne (AU)
  • Department of Endocrinology, University Colorado Health Sciences Center, Aurora, CO 80045; and
  • University of California, Los Angeles (US)
Venue
Proceedings of the National Academy of Sciences
Published
2008-02-05
Volume
105
Issue
5
Pages
1739-1744
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2012248291
Cited by
553
References
42
Citations by year
2026: 17 · 2025: 10 · 2024: 18 · 2023: 29 · 2022: 29 · 2021: 29 · 2020: 40 · 2019: 25 · 2018: 37 · 2017: 34 · 2016: 31 · 2015: 52 · 2014: 43 · 2013: 42 · 2012: 36
FWCI
10.82
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • RMIT Research Repository (RMIT University Library) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Diabetes Australia Research Trust
  • Diabetes Australia
  • Heart Research Institute
  • Hungarian Scientific Research Fund
  • National Institutes of Health
  • Medical Research Council
  • Australian Research Council
  • National Health and Medical Research Council (472650)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 60484, K01DK060484, R21DK073227, DK73227)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
HSP72, heat shock proteins, insulin resistance, obesity, type 2 diabetes, JNK phosphorylation, skeletal muscle, inflammation, high-fat diet, impaired glucose tolerance, hyperinsulinemia, hyperglycemia, IκB kinase, TNF-α
MeSH terms
Animals, Blood Glucose, Humans, Hyperinsulinism, Hyperthermia, Induced, Insulin, Insulin Resistance, Liver, Mice, Transgenic, Obesity, Oximes, Phosphorylation, Piperidines, Muscle, Skeletal, MAP Kinase Kinase 4, HSP72 Heat-Shock Proteins, Mice, I-kappa B Kinase, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HSP72 protects against obesity-induced insulin resistance. https://app.cochat.ai/papers/10.1073/pnas.0705799105
The paper
Chung, J., Nguyen, A.-K., Henstridge, D. C., Holmes, A. G., Chan, M. H. S., Mesa, J. L., Lancaster, G. I., Southgate, R. J., Bruce, C. R., Duffy, S. J., Horvath, I., Mestril, R., Watt, M. J., Hooper, P. L., Kingwell, B. A., Vigh, L., Hevener, A., & Febbraio, M. A. (2008). HSP72 protects against obesity-induced insulin resistance. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0705799105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.